Richter’s Uterine Fibroid Drug Esmya Hit By Liver Safety Concerns In EU

Side effects
Richter's Esmya is under scrutiny over reports of liver damage in the EU
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet